Literature DB >> 7698003

Report of the fourth international workshop on human chromosome 11 mapping 1994.

V van Heyningen, P F Little.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7698003     DOI： 10.1159/000133953

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN： 0301-0171


× No keyword cloud information.
  5 in total

1.  Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13.

Authors:  Y Gong; M Vikkula; L Boon; J Liu; P Beighton; R Ramesar; L Peltonen; H Somer; T Hirose; B Dallapiccola; A De Paepe; W Swoboda; B Zabel; A Superti-Furga; B Steinmann; H G Brunner; A Jans; R G Boles; W Adkins; M J van den Boogaard; B R Olsen; M L Warman
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Genomewide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. Pima Diabetes Gene Group.

Authors:  R A Norman; D B Thompson; T Foroud; W T Garvey; P H Bennett; C Bogardus; E Ravussin
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

3.  A gene for autosomal dominant nonsyndromic hearing loss (DFNA12) maps to chromosome 11q22-24.

Authors:  K Verhoeven; G Van Camp; P J Govaerts; W Balemans; I Schatteman; M Verstreken; L Van Laer; R J Smith; M R Brown; P H Van de Heyning; T Somers; F E Offeciers; P J Willems
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Homozygosity by descent for a rare mutation in the myophosphorylase gene is associated with variable phenotypes in a Druze family with McArdle disease.

Authors:  S Iyengar; H Kalinsky; S Weiss; M Korostishevsky; M Sadeh; Y Zhao; K K Kidd; B Bonne-Tamir
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

5.  Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion.

Authors:  Veronica van Heyningen; Jan M N Hoovers; Jan de Kraker; John A Crolla
Journal:  J Med Genet       Date:  2007-07-14       Impact factor: 6.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.